目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Device Type
1.2.2. Anatomical Site
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Device Type Segment
2.2.2. Anatomical Site Segment
2.2.3. End Use Segment
2.2.4. Regional Outlook
2.3. Competitive Insights

Chapter 3. Global Peripheral Artery Disease Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of diabetes and smoking
3.2.1.2. Advancements in endovascular technologies
3.2.1.3. Growing elderly population and PAD risk
3.2.2. Market restraint analysis
3.2.2.1. High cost of advanced revascularization procedures
3.2.2.2. Limited access to PAD treatment in low-income regions
3.3. Peripheral Artery Disease Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Peripheral Artery Disease Market: Device Type Estimates & Trend Analysis
4.1. Peripheral Artery Disease Market: Device Type Dashboard
4.2. Peripheral Artery Disease Market: Device Type Movement Analysis
4.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Device Type, 2021 - 2033 (USD Million)
4.4. Endovascular Devices
4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.5. Surgical Devices
4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Peripheral Artery Disease Market: Anatomical Site Estimates & Trend Analysis
5.1. Peripheral Artery Disease Market: Anatomical Site Dashboard
5.2. Peripheral Artery Disease Market: Anatomical Site Movement Analysis
5.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Anatomical Site, 2021 - 2033 (USD Million)
5.4. Aortoiliac
5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.5. Femoropopliteal
5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.6. Tibial
5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Peripheral Artery Disease Market: End Use Estimates & Trend Analysis
6.1. Peripheral Artery Disease Market: End Use Dashboard
6.2. Peripheral Artery Disease Market: End Use Movement Analysis
6.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by End Use, 2021 - 2033 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.5. Outpatient Facilities
6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Peripheral Artery Disease Market: Regional Estimates & Trend Analysis by Country, Device Type, Anatomical Site & End Use
7.1. Global Peripheral Artery Disease Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2021 - 2033
7.3. North America
7.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Regulatory framework/ reimbursement structure
7.3.4.3. Competitive scenario
7.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
7.4. Europe
7.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework/ reimbursement structure
7.4.9.3. Competitive scenario
7.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
7.5.7. South Korea
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
7.6. Latin America
7.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
7.7. MEA
7.7.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
7.7.3. South Africa
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.3.4. BD
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Bentley InnoMed
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Scitech Medical
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Abbott Laboratories
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Boston Scientific Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. W. L. Gore & Associates, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Medtronic
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Cook
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Terumo Corporation
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. iVascular
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Getinge AB
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Biotronik SE & Co KG
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 4 Global peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million
Table 5 Global peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 6 Global peripheral artery disease market, by region, 2021 - 2033 (USD Million)
Table 7 North America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
Table 8 North America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 9 North America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 10 North America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 11 U.S. peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 12 U.S. peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 13 U.S. peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 14 Canada peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 15 Canada peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 16 Canada peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 17 Mexico peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 18 Mexico peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 19 Mexico peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 20 Europe peripheral artery disease market, by country, 2021 - 2033 (USD Million)
Table 21 Europe peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 22 Europe peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 23 Europe peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 24 UK peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 25 UK peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 26 UK peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 27 Germany peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 28 Germany peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 29 Germany peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 30 France peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 31 France peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 32 France peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 33 Italy peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 34 Italy peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 35 Italy peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 36 Spain peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 37 Spain peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 38 Spain peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 39 Denmark peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 40 Denmark peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 41 Denmark peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 42 Sweden peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 43 Sweden peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 44 Sweden peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 45 Norway peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 46 Norway peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 47 Norway peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 48 Asia Pacific peripheral artery disease market, by country, 2021 - 2033 (USD Million)
Table 49 Asia Pacific peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 50 Asia Pacific peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 51 Asia Pacific peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 52 Japan peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 53 Japan peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 54 Japan peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 55 China peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 56 China peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 57 China peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 58 India peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 59 India peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 60 India peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 61 Australia peripheral artery disease market, by country, 2021 - 2033 (USD Million)
Table 62 Australia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 63 Australia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 64 Australia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 65 Thailand peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 66 Thailand peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 67 Thailand peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 68 South Korea peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 69 South Korea peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 70 South Korea peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 71 Latin America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
Table 72 Latin America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 73 Latin America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 74 Latin America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 75 Brazil peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 76 Brazil peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 77 Brazil peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 78 Argentina peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 79 Argentina peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 80 Argentina peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 81 MEA peripheral artery disease market, by country, 2021 - 2033 (USD Million)
Table 82 MEA peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 83 MEA peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 84 MEA peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 85 South Africa peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 86 South Africa peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 87 South Africa peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 89 Saudi Arabia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 90 Saudi Arabia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 91 UAE peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 92 UAE peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 93 UAE peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 94 Kuwait peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
Table 95 Kuwait peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
Table 96 Kuwait peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
Table 97 Participant’s overview
Table 98 Financial performance
Table 99 Key companies undergoing expansions
Table 100 Key companies undergoing acquisitions
Table 101 Key companies undergoing collaborations
Table 102 Key companies launching new products
Table 103 Key companies undergoing partnerships
Table 104 Key companies undertaking other strategies

List of Figures
Fig. 1 Peripheral artery disease market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Peripheral artery disease market revenues, 2024 (USD Millions)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 Peripheral artery disease market Device type outlook:
Fig. 14 Peripheral artery disease market: Device type movement analysis
Fig. 15 Segment dashboard
Fig. 16 Global endovascular devices market, 2021 - 2033 (USD Million)
Fig. 17 Global surgical devices market, 2021 - 2033 (USD Million)
Fig. 18 Peripheral artery disease market Anatomical site outlook:
Fig. 19 Peripheral artery disease market: Anatomical site movement analysis
Fig. 20 Global aortoiliac market, 2021 - 2033 (USD Million)
Fig. 21 Global femoropopliteal market, 2021 - 2033 (USD Million)
Fig. 22 Global tibial market, 2021 - 2033 (USD Million)
Fig. 23 Peripheral artery disease market end use outlook:
Fig. 24 Peripheral artery disease market: end use movement analysis
Fig. 25 Global hospitals market, 2021 - 2033 (USD Million)
Fig. 26 Global outpatient facilities market, 2021 - 2033 (USD Million)
Fig. 27 Global others market, 2021 - 2033 (USD Million)
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 North America peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 30 U.S. peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 31 Canada peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 32 Mexico peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 33 Europe peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 34 Germany peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 35 UK peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 36 France peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 37 Italy peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 38 Spain peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 39 Sweden peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 40 Denmark peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 41 Norway peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 42 Asia Pacific peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 43 Japan peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 44 China peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 45 India peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 46 Australia peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 47 Thailand peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 48 South Korea peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 49 Latin America peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 50 Brazil peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 51 Argentina peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 52 MEA peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 53 South Africa peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 54 Saudi Arabia peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 55 UAE peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 56 Kuwait peripheral artery disease market, 2021 - 2033 (USD Million)
Fig. 57 Market Participant Categorization
Fig. 58 Strategy mapping